These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7299663)

  • 21. Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
    Wagner JG; Wexler D; Ağabeyoğlu IT; Bergstrom RF; Sakmar E; Kay DR
    J Lab Clin Med; 1981 Apr; 97(4):487-501. PubMed ID: 7205057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring prednisone and prednisolone.
    Jusko WJ; Rose JQ
    Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal model.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1988; 9(4):363-76. PubMed ID: 3207856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination and prediction of tissue binding of prednisolone in the rabbit.
    Khalafallah N; Jusko WJ
    J Pharm Sci; 1984 Mar; 73(3):362-6. PubMed ID: 6716244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis.
    Boudinot FD; Jusko WJ
    J Pharm Sci; 1984 Jun; 73(6):774-80. PubMed ID: 6204037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients.
    Gambertoglio JG; Holford HG; Lizak PS; Birnbaum JL; Salvatierra O; Amend WJ
    Am J Kidney Dis; 1984 May; 3(6):425-9. PubMed ID: 6372445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prednisone and prednisolone interconversion in the rabbit utilizing unbound concentrations.
    Hammarlund-Udenaes M; Benet LZ
    Biopharm Drug Dispos; 1991; 12(6):467-77. PubMed ID: 1932610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF; Benet LZ
    Clin Pharmacol Ther; 1986 Apr; 39(4):425-9. PubMed ID: 3956058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prednisolone clearance at steady state in dogs.
    Frey FJ; Frey BM; Greither A; Benet LZ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):287-91. PubMed ID: 7441495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisolone binding to plasma proteins in domestic species.
    Alvinerie M; Houin G; Toutain PL
    J Pharm Sci; 1988 Nov; 77(11):937-8. PubMed ID: 3225753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid pharmacokinetics in liver disease.
    Uribe M; Go VL
    Clin Pharmacokinet; 1979; 4(3):233-40. PubMed ID: 383357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prednisolone binding to albumin and transcortin in the presence of cortisol.
    Rocci ML; D'Ambrosio R; Johnson NF; Jusko WJ
    Biochem Pharmacol; 1982 Feb; 31(3):289-92. PubMed ID: 7073761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
    Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
    Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
    Murata R; Haughey DB; Jusko WJ
    Drug Metab Dispos; 1990; 18(4):403-8. PubMed ID: 1976060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.
    Tozer TN; Gambertoglio JG; Furst DE; Avery DS; Holford NH
    J Pharm Sci; 1983 Dec; 72(12):1442-6. PubMed ID: 6663482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisolone metabolism and excretion in the isolated perfused rat kidney.
    Rocci ML; Szefler SJ; Acara M; Jusko WJ
    Drug Metab Dispos; 1981; 9(3):177-82. PubMed ID: 6113924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.